PWE-109 Measurement of Infliximab and Anti-Infliximab Antibodies - Analytical Aspects and Clinical Implications: Abstract PWE-109 Table

Gut - United Kingdom
doi 10.1136/gutjnl-2013-304907.397
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

PWE-089 Outcomes of Patients With Crohn’S Disease: Azathioprine Tolerant and Azathioprine Intolerant: Abstract PWE-089 Table

Gut
Gastroenterology
2013English

PWE-133 Oesophageal Varices Screening - Are We Meeting the Guidelines?: Abstract PWE-133 Table 1

Gut
Gastroenterology
2013English

PWE-033 the Incidence and Cost of Unexpected Hospital Attendance Following Elective Outpatient Flexible Sigmoidoscopy: Abstract PWE-033 Table

Gut
Gastroenterology
2013English

PWE-071 the Management of Small Early Rectal Cancers—network MDT Results: Abstract PWE-071 Table 1

Gut
Gastroenterology
2012English

PWE-016 Pelvic Radiation Disease – A Comparison of Reported Symptoms in Oncology and Gastroenterology Clinics: Abstract PWE-016 Table 1

Gut
Gastroenterology
2014English

PWE-195 Non-Neoplastic Diagnoses Within the NHS Bowel Cancer Screening Programme: Abstract PWE-195 Table 1

Gut
Gastroenterology
2012English

PWE-134 Outcomes for Liver Disease Patients Admitted to a District General Hospital: Abstract PWE- Table 1

Gut
Gastroenterology
2013English

PWE-100 How Commonly Does Faecal Calprotectin Alter Management in Patients With I.B.D?: Abstract PWE-100 Table

Gut
Gastroenterology
2013English

Detection of Anti-Infliximab Antibodies Is Impacted by Antibody Titer, Infliximab Level and IgG4 Antibodies: A Systematic Comparison of Three Different Assays

Therapeutic Advances in Gastroenterology
Gastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy